These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22890797)

  • 41. Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes.
    Rosenson RS; Gelb MH
    Curr Cardiol Rep; 2009 Nov; 11(6):445-51. PubMed ID: 19863869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
    Ling L; Ismail M; Du Y; Yao C; Li X
    Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
    Accardo A; Salsano G; Morisco A; Aurilio M; Parisi A; Maione F; Cicala C; Tesauro D; Aloj L; De Rosa G; Morelli G
    Int J Nanomedicine; 2012; 7():2007-17. PubMed ID: 22619538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.
    Menschikowski M; Hagelgans A; Kostka H; Eisenhofer G; Siegert G
    Neoplasia; 2008 Nov; 10(11):1195-203. PubMed ID: 18953428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.
    Quach ND; Arnold RD; Cummings BS
    Biochem Pharmacol; 2014 Aug; 90(4):338-48. PubMed ID: 24907600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Secretory phospholipase A
    Østrem RG; Parhamifar L; Pourhassan H; Clergeaud G; Nielsen OL; Kjær A; Hansen AE; Andresen TL
    J Control Release; 2017 Sep; 262():212-221. PubMed ID: 28754610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model.
    Roy Chaudhuri T; Straubinger NL; Pitoniak RF; Hylander BL; Repasky EA; Ma WW; Straubinger RM
    Mol Cancer Ther; 2016 Jan; 15(1):84-93. PubMed ID: 26516158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lung mast cells are a source of secreted phospholipases A2.
    Triggiani M; Giannattasio G; Calabrese C; Loffredo S; Granata F; Fiorello A; Santini M; Gelb MH; Marone G
    J Allergy Clin Immunol; 2009 Sep; 124(3):558-65, 565.e1-3. PubMed ID: 19541351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody.
    Ikegami S; Yamakami K; Ono T; Sato M; Suzuki S; Yoshimura I; Asano T; Hayakawa M; Tadakuma T
    Hum Gene Ther; 2006 Oct; 17(10):997-1005. PubMed ID: 17032155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of secretory phospholipase A2 XIIA in the brain and its role in lipid metabolism and cognition.
    Ee SM; Lo YL; Shui G; Wenk MR; Shin EJ; Kim HC; Ong WY
    Mol Neurobiol; 2014 Aug; 50(1):60-75. PubMed ID: 24464264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrone-targeted liposomes for mitoxantrone delivery via estrogen receptor: In vivo targeting efficacy, antitumor activity, acute toxicity and pharmacokinetics.
    Xu G; Tang H; Chen J; Zhu M; Xie Y; Li Y; Hao Q; Sun Y; Cong D; Meng Q; Ren Z; Li Q; Bao H; Lv Z; Li Y; Pei J
    Eur J Pharm Sci; 2021 Jun; 161():105780. PubMed ID: 33667664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide.
    Triggiani M; Granata F; Petraroli A; Loffredo S; Frattini A; Staiano RI; Monaco G; Marone G
    Int Arch Allergy Immunol; 2009; 150(2):144-55. PubMed ID: 19439980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency.
    Liu Y; He M; Niu M; Zhao Y; Zhu Y; Li Z; Feng N
    Int J Nanomedicine; 2015; 10():3081-95. PubMed ID: 25960649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of secretory phospholipase A 2 in insulitis of human transplanted pancreas and its insulinotropic effect on isolated rat islets.
    Ishida-Oku M; Iwase M; Sonoki K; Sasaki N; Imoto H; Uchizono Y
    Islets; 2010; 2(5):274-7. PubMed ID: 21099324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antivascular and antitumor activities of liposome-associated drugs.
    Straubinger RM; Arnold RD; Zhou R; Mazurchuk R; Slack JE
    Anticancer Res; 2004; 24(2A):397-404. PubMed ID: 15152936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.
    Singh DK; Subbaiah PV
    J Lipid Res; 2007 Mar; 48(3):683-92. PubMed ID: 17148553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.